Literature DB >> 14713748

Dietary fat and prostate cancer.

Neil Fleshner1, P Scott Bagnell, Laurence Klotz, Vasundara Venkateswaran.   

Abstract

PURPOSE: Data from histopathological and migratory studies suggest that 1 or more late stage environmental promoters are involved in the development of clinical carcinoma of the prostate. Laboratory investigations and variously designed epidemiological studies in man have suggested that dietary fat may be one of these candidate tumor promoters but other studies have questioned this association. The biologically plausible associations that have been hypothesized include total energy consumption, altered androgen metabolism, oxidative stress, specific fatty acid consumption and pesticide intake. We provide a critical appraisal of the existing evidence for an association between dietary fat consumption and prostate cancer, and review the biologically plausible relationships.
MATERIALS AND METHODS: All 33 published case-control and cohort studies that examined the relationship between prostate cancer and dietary fat or specific fatty food types were critically appraised. Eight studies suggested a statistically significant association, and many studies noted significant associations for specific types of fatty foods (eg milk or meat) and prostate cancer.
RESULTS: In light of the inherent biases in the methodology of studying dietary fat intake and carcinoma of the prostate, we conclude that the evidence is consistent.
CONCLUSIONS: Corroborative studies in humans are required to better define this relationship. Prospective studies of dietary intervention should be encouraged.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14713748     DOI: 10.1097/01.ju.0000107838.33623.19

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  30 in total

1.  Will metformin postpone high-fat diet promotion of TRAMP mouse prostate cancer development and progression?

Authors:  Hua Xu; Meng-Bo Hu; Pei-de Bai; Wen-Hui Zhu; Qiang Ding; Hao-Wen Jiang
Journal:  Int Urol Nephrol       Date:  2014-08-27       Impact factor: 2.370

2.  Autoxidation of gallic acid induces ROS-dependent death in human prostate cancer LNCaP cells.

Authors:  Larry H Russell; Elizabeth Mazzio; Ramesh B Badisa; Zhi-Ping Zhu; Maryam Agharahimi; Ebenezer T Oriaku; Carl B Goodman
Journal:  Anticancer Res       Date:  2012-05       Impact factor: 2.480

3.  Inhibition of 5-lipoxygenase triggers apoptosis in prostate cancer cells via down-regulation of protein kinase C-epsilon.

Authors:  Sivalokanathan Sarveswaran; Vijayalakshmi Thamilselvan; Chaya Brodie; Jagadananda Ghosh
Journal:  Biochim Biophys Acta       Date:  2011-07-30

4.  Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice.

Authors:  Uddhav P Kelavkar; Wayne Glasgow; Sandra J Olson; Barbara A Foster; Scott B Shappell
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

Review 5.  Metabolic alterations and targeted therapies in prostate cancer.

Authors:  Richard Flavin; Giorgia Zadra; Massimo Loda
Journal:  J Pathol       Date:  2010-11-16       Impact factor: 7.996

6.  Circulating fatty acids and prostate cancer risk in a nested case-control study: the Multiethnic Cohort.

Authors:  Song-Yi Park; Lynne R Wilkens; Susanne M Henning; Loïc Le Marchand; Kun Gao; Marc T Goodman; Suzanne P Murphy; Brian E Henderson; Laurence N Kolonel
Journal:  Cancer Causes Control       Date:  2008-09-27       Impact factor: 2.506

7.  Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism.

Authors:  Dorrah Deeb; Xiaohua Gao; Hao Jiang; Branislava Janic; Ali S Arbab; Yon Rojanasakul; Scott A Dulchavsky; Subhash C Gautam
Journal:  Biochem Pharmacol       Date:  2009-09-24       Impact factor: 5.858

8.  Cytosolic phospholipase A2-alpha: a potential therapeutic target for prostate cancer.

Authors:  Manish I Patel; Jaskirat Singh; Marzieh Niknami; Caroline Kurek; Mu Yao; Sasa Lu; Fiona Maclean; Nicholas J C King; Michael H Gelb; Kieran F Scott; Pamela J Russell; John Boulas; Qihan Dong
Journal:  Clin Cancer Res       Date:  2008-12-15       Impact factor: 12.531

9.  5α-Reductase Isozymes in the Prostate.

Authors:  Yuan-Shan Zhu; Guang-Huan Sun
Journal:  J Med Sci       Date:  2005

10.  Pristimerin Induces Apoptosis in Prostate Cancer Cells by Down-regulating Bcl-2 through ROS-dependent Ubiquitin-proteasomal Degradation Pathway.

Authors:  Yong Bo Liu; Xiaohua Gao; Dorrah Deeb; Ali S Arbab; Subhash C Gautam
Journal:  J Carcinog Mutagen       Date:  2013-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.